RSS feed

Publications by Tone Gretland Valderhaug

19 publications found

Original articles

Bechensteen BT, Sithiravel C, Strøm-Roum EM, Ruud HK, Kravdal G, Winther JA, Valderhaug TG (2024)
Post-bariatric pregnancy is associated with vitamin K1 deficiency, a case control study
BMC Pregnancy Childbirth, 24 (1), 229
DOI 10.1186/s12884-024-06407-0, PubMed 38566061

Hjelmesæth J, Lund RS, Sagen JV, Valderhaug TG (2022)
Weight-loss drugs - for whom, how, how long?
Tidsskr Nor Laegeforen, 142 (6)
DOI 10.4045/tidsskr.22.0115, PubMed 35383456

Rønningen T, Dahl MB, Valderhaug TG, Cayir A, Keller M, Tönjes A, Blüher M, Böttcher Y (2021)
m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity
Front Endocrinol (Lausanne), 12, 778875
DOI 10.3389/fendo.2021.778875, PubMed 34950106

Doncheva AI, Norheim FA, Hjorth M, Grujic M, Paivandy A, Dankel SN, Hertel JK, Valderhaug TG, Böttcher Y, Fernø J, Mellgren G, Dalen KT, Pejler G, Kolset SO (2021)
Serglycin Is Involved in Adipose Tissue Inflammation in Obesity
J Immunol, 208 (1), 121-132
DOI 10.4049/jimmunol.2100231, PubMed 34872979

Valderhaug TG, Slavich GM (2020)
Assessing Life Stress: A Critical Priority in Obesity Research and Treatment
Obesity (Silver Spring), 28 (9), 1571-1573
DOI 10.1002/oby.22911, PubMed 32729167

Borgeraas H, Hjelmesæth J, Birkeland KI, Fatima F, Grimnes JO, Gulseth HL, Halvorsen E, Hertel JK, Hillestad TOW, Johnson LK, Karlsen TI, Kolotkin RL, Kvan NP, Lindberg M, Lorentzen J, Nordstrand N, Sandbu R, Seeberg KA, Seip B, Svanevik M, Valderhaug TG, Hofsø D (2019)
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study
BMJ Open, 9 (6), e024573
DOI 10.1136/bmjopen-2018-024573, PubMed 31167860

Rønningen R, Wammer ACP, Grabner NH, Valderhaug TG (2019)
Associations between Lifetime Adversity and Obesity Treatment in Patients with Morbid Obesity
Obes Facts, 12 (1), 1-13
DOI 10.1159/000494333, PubMed 30654360

Valderhaug TG, Sharma A, Kravdal G, Rønningen R, Nermoen I (2017)
The usage of fasting glucose and glycated hemoglobin for the identification of unknown type 2 diabetes in high risk patients with morbid obesity
Scand J Clin Lab Invest, 77 (7), 505-512
DOI 10.1080/00365513.2017.1347958, PubMed 28715238

Valderhaug TG, Aasheim ET, Sandbu R, Jakobsen GS, Småstuen MC, Hertel JK, Hjelmesæth J (2016)
The association between severity of King's Obesity Staging Criteria scores and treatment choice in patients with morbid obesity: a retrospective cohort study
BMC Obes, 3, 51
DOI 10.1186/s40608-016-0133-1, PubMed 27980795

Valderhaug TG, Hertel JK, Nordstrand N, Dale PO, Hofsø D, Hjelmesæth J (2015)
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Diabetol Metab Syndr, 7, 46
DOI 10.1186/s13098-015-0040-5, PubMed 26015809

Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A (2012)
Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses
Transplantation, 94 (7), 714-20
DOI 10.1097/TP.0b013e31825f4434, PubMed 22965263

Valderhaug TG, Hjelmesæth J, Hartmann A, Røislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011)
The association of early post-transplant glucose levels with long-term mortality
Diabetologia, 54 (6), 1341-9
DOI 10.1007/s00125-011-2105-9, PubMed 21409415

Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
Clin J Am Soc Nephrol, 5 (4), 616-22
DOI 10.2215/CJN.07501009, PubMed 20133490

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
DOI 10.1093/ndt/gfp617, PubMed 19934089

Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2009)
Glucose tolerance before and after renal transplantation
Nephrol Dial Transplant, 25 (3), 985-92
DOI 10.1093/ndt/gfp566, PubMed 19854851

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
DOI 10.1097/TP.0b013e3181af1f53, PubMed 19667949

Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
Transplantation, 84 (9), 1125-30
DOI 10.1097/01.tp.0000287191.45032.38, PubMed 17998867

Other articles

Sharif A, Hecking M, de Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, Marchetti P, Pacini G, Ojo A, Takahara S, Larsen JL, Budde K, Eller K, Pascual J, Jardine A, Bakker SJ, Valderhaug TG, Jenssen TG, Cohney S, Säemann MD (2014)
Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions
Am J Transplant, 14 (9), 1992-2000
DOI 10.1111/ajt.12850, PubMed 25307034

Valderhaug TG, Bergrem HA, Jenssen T, Hjelmesæth J (2012)
Comment on: Chakkera et al. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 2011;34:2141-2145
Diabetes Care, 35 (3), e26; author reply e27
DOI 10.2337/dc11-2046, PubMed 22355029